Business Overview
Prasol Chemicals Limited, incorporated in 1992 and headquartered in Navi Mumbai, is a forward integrated manufacturer of acetone based and phosphorous based specialty chemicals, along with other specialty chemicals involving complex and differentiated chemistries. Its product portfolio comprises over 150 specialty chemical products, made up of 21 acetone based products, 53 phosphorous based products and 76 other specialty chemicals such as surfactants, esters and acids. These products are sold into five application industries, namely performance chemicals including lubricant additives and mining chemicals, paints, inks, construction and adhesives (PICA), pharmaceuticals, agrochemicals, and home and personal care.
The Company operates two manufacturing facilities in Raigad district of Maharashtra, at Khopoli spread over 1,20,604 sq. mt. and at Mahad spread over 1,19,423 sq. mt., with an aggregate installed capacity of 98,644 MT per annum. The company has over 1,600 customers and exported to 69 countries, supported by a Government of India certified 3 Star Export House status and European REACH and K-REACH registrations. Marquee customers include Alembic Pharmaceuticals Limited, Lubrizol India Private Limited, Rossari Biotech Limited, Clean Science and Technology Limited, Gharda Chemicals Limited, Croda India Company Private Limited and Supriya Lifescience Limited.
IPO Synopsis
| Particulars | Details |
|---|---|
| IPO Date | Sep 8 to Sep 10, 2026 |
| Face Value | ₹2 per share |
| Price Band | ₹643 to ₹676 per share |
| Lot Size | 22 shares and in multiples thereof |
| Issue Size | ₹500 Crores |
| Issue Type | Fresh Issue – ₹80 Crores; Offer for Sale – ₹420 Crores |
Objective of the Issue
-
Repayment and / or pre-payment, in full or in part, of certain outstanding borrowings availed by the Company – ₹60.00 Crores.
-
General corporate purposes.
-
The Company will not receive any proceeds from the Offer for Sale of ₹420.00 Crores, which accrues entirely to the Selling Shareholders.
Strengths
-
Highly Diversified Product Portfolio Across Application Industries
Over 150 specialty chemical products span five application industries. Prasol was India’s largest acetone importer during 2023-2025 and the country’s only isophorone manufacturer, and ranked among the top five yellow phosphorus users during 2022-2025. Domestic competition remains limited given few acetone specialty manufacturers. -
Well Established R&D Capabilities with a Strong Product Pipeline
The Khopoli R&D facility runs a 37 member in house team including 4 PhDs and 25 chemists. Thirteen products were commercialised between April 2023 and June 2026, with 40 more in development of which 9 have cleared pilot stage, driving customer stickiness and higher margins. -
Long Standing Relationships with a Diversified Customer Base and Global Presence
Prasol catered to 1,618 customers in Fiscal 2026, with repeat customers contributing 93.28% of revenue from operations. Individual relationships run 10 to 16 years, expanding from one product to as many as nine. It is a 3 Star Export House distributing across 69 countries and six continents.
Risks
-
Raw Material Price Volatility and Supplier Concentration
Cost of raw materials was 61.15% of total expenses in Fiscal 2026. Acetone fell 26.89% to ₹59.81 per kg while yellow phosphorus rose 8.79% to ₹353.81 per kg. The top 3 suppliers supply 39.75% of material consumed, with no long-term agreements in place. -
Rising Working Capital Intensity
Total working capital requirement nearly tripled, from ₹83.98 Crores in Fiscal 2024 to ₹151.90 Crores in Fiscal 2025 and ₹229.56 Crores in Fiscal 2026. Net working capital days stretched from 35 to 49, as trade payable days shortened from 98 to 87. -
Persistent Under Utilisation and Losses at Mahad
Mahad ran at 44.09%, 25.18% and 12.72% capacity utilisation in Fiscal 2026, 2025 and 2024. It was non-operational from October 27, 2023 to May 3, 2024 following MPCB closure directions after a gas leakage incident, and still lost ₹12.17 Crores before exceptional items in Fiscal 2026.
Financial Snapshot
| Period Ended | FY26 | FY25 | FY24 |
|---|---|---|---|
| Total Income | 1,237.85 | 1,015.54 | 887.56 |
| YoY Growth | 21.9% | 14.4% | – |
| EBITDA | 139.32 | 87.77 | 60.53 |
| YoY Growth | 58.7% | 45.0% | – |
| EBITDA Margin | 11.25% | 8.64% | 6.82% |
| Profit After Tax | 83.12 | 43.57 | 18.13 |
| YoY Growth | 90.8% | 140.3% | – |
| PAT Margin | 6.71% | 4.29% | 2.04% |
| ROE | 20.37% | 12.57% | 5.71% |
| Net Worth | 448.51 | 367.46 | 325.84 |
| Total Borrowings | 110.06 | 101.05 | 82.07 |
Conclusion
Prasol Chemicals is best read as an improving specialty chemicals business still mid-transition, not yet a proven compounder. Revenue grew 22% in FY26 to ₹1,237.85 crore, EBITDA margin expanded from 6.82% to 11.25%, and PAT nearly doubled to ₹83.12 crore, lifting ROE above 20%. A diversified 150 product portfolio, near monopoly positioning in isophorone and acetone, 93% repeat customer revenue, and a genuine R&D pipeline support the growth case. However, investors should weigh rising working capital intensity, raw material and supplier concentration, and Mahad’s persistent underutilisation and losses since its 2023 shutdown. With 84% of the issue structured as an Offer for Sale and little fresh capital reaching the balance sheet, this listing is primarily a promoter exit rather than a growth funding event. Given the improving margin trajectory and a reasonable valuation within the specialty chemicals space. We Recommend the IPO for Subscribing for Listing Gains.
